TWT's (Third Wave Technologies') Invader technology sensitivity confirmed:
This article was originally published in Clinica
Executive Summary
Third Wave Technologies' (TWT) RNA Invader technology, claimed to be a cost-effective alternative to PCR, can detect changes in gene expression level as small as 20%, according to an assessment published in the July issue of Nature Biotechnology. The assessment, by TWT (Madison, Wisconsin), also confirmed that Invader assays can routinely detect as few as 6,000 copies of RNA, and can detect a single target sequence in a pool of more than 20,000 sequences of closely related RNA. TWT has licensed the technology to Dade Behring.
You may also be interested in...
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.
Medicare Reimbursement For Part B Drugs Is 48% Above 340B Prices To Hospitals, MedPAC Finds
New study updates past commission analyses and highlights the significant margin between Medicare payments for drugs and the prices paid by 340B-eligible providers.
Drug Shortages, Inspections In Focus At US FDA Appropriations Hearing
Commissioner Robert Califf discussed the agency’s request for $12.3m to address shortages and legislation to require that manufacturers provide more detailed information about increased demand and supply chain vulnerabilities.